Idiotype-specific T lymphocytes. II. capability of generation of idiotype-specific T lymphocytes is determined by corresponding VH gene

Anti-idiotypic antibodies and the induction of specific tumor immunity

Immunization with anti-idiotypic antibodies is a strategy which, with variable success, can be used to elicit or amplify antigen-specific immune response. This article discusses the manipulation of specific idiotypes in anti-tumor immunity, emphasizing the appropriate consideration of genetic restriction, the choice of idiotype specificity, and the route of immunization. Two independent pathways are outlined: One uses anti-idiotypic antibodies to select and amplify tumor-specific T and B cells via their preexisting antigen-specific receptors, and the other uses anti-idiotypes as primary internal image immunogens to elicit immune recognition of determinants shared by the anti-idiotype and by tumor-associated antigens. Both pathways can be manipulated in attempts to favor the generation of anti-tumor effector cells and minimize the elicitation of suppression. Anti-idiotypic immunization can be utilized to induce therapeutic immune reactivity in hosts lacking effective direct anti-tumor responses. By stimulating 'silent', or normally suppressed, T and B cell clones, appropriate immunization strategies can circumvent immune regulatory pathways associated with suppressor cells and factors derived from such cells. In these studies, adequate characterization of antitumor idiotype and anti-idiotype specificities is key to the experimental approach to tumor therapy using antibodies. The importance of individual host genetic variation in the specificity and scope of immune response to anti-idiotypic immunoglobulins is unknown, and remains an important potential barrier to therapeutic management.

Influence of kappa and IgH genes on the T helper cell response to p-azobenzenearsonate tyrosine

Immunization of mice with the p-azobenzenearsonate-L-tyrosine conjugate (ABA-Tyr) leads to the activation of ABA-specific T helper cells capable of proliferating in vitro in the presence of the corresponding antigen. This response is under a dual genetic regulation by H-2 and non-H-2 linked genes, and H-2d mice are high-responder. We demonstrate here, using strains congenic to BALB/c for chromosomes (Chr.) 6 or 12 that this T cell response is also influenced by kappa and IgH linked genes. Double congenic mice indicate that Chr.6 and Chr.12 genes have a complementary effect on the response which cannot be predicted solely by the alleles expressed on either of the two chromosomes. In addition, responses in Bailey's inbred recombinant mice allow a possible mapping of the Chr.12 gene at the 5' end of the IgH complex and of the VH-dextran gene family. The mechanisms which may account for the influence of immunoglobulin gene products on the ABA-specific T cell repertoire are discussed.

Cytotoxic T lymphocyte clone recognizing self idiotype: its regulatory role in antibody production

MOPC 104E idiotype-specific cytotoxic T lymphocyte (CTL) clones were established. The clone KA1.02 specifically killed MOPC 104E cells and inhibited anti-dextran antibody production in an idiotype-specific manner. Both cytotoxicity and antibody inhibition were restricted to the cross-reactive idiotype and class I histocompatibility antigen. The data presented here provide definitive evidence that the self idiotype is the immunogenic determinant recognized by T lymphocytes in association with the major histocompatibility complex product. A regulatory role of CTL in antibody response is proposed.